𝔖 Bobbio Scriptorium

✦ LIBER ✦

Laboratory surrogates for anti-atherosclerotic drug development

✍ Scribed by Evan Stein

Book ID: 113974669
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 77 KB
Volume: 87
Category: Article
ISSN: 0002-9149
DOI: 10.1016/s0002-9149(01)01421-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Genomic surrogates for cancer drug devel

Genomic surrogates for cancer drug development

✍ Karol Sikora 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 94 KB

Application of intravascular ultrasound

Application of intravascular ultrasound in anti-atherosclerotic drug development

✍ Nicholls, Stephen J.; Sipahi, Ilke; Schoenhagen, Paul; Crowe, Tim; Tuzcu, E. Mur 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 597 KB

Imaging biomarkers as surrogate endpoint

Imaging biomarkers as surrogate endpoints for drug development

✍ Wolf S. Richter 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 100 KB

Albuminuria as a surrogate marker for dr

Albuminuria as a surrogate marker for drug development: A European Regulatory perspective

✍ Calvo, Gonzalo; de Andres-Trelles, Fernando 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 49 KB

Simple laboratory procedures for the eva

Simple laboratory procedures for the evaluation of topically-active anti-inflammatory drugs

✍ E. Myles Glenn; B. J. Bowman; N. A. Rohloff 📂 Article 📅 1978 🏛 SP Birkhäuser Verlag Basel 🌐 English ⚖ 545 KB

Development and validation of a new mode

Development and validation of a new model of inflammation in the cat and selection of surrogate endpoints for testing anti-inflammatory drugs

✍ J. M. GIRAUDEL; A. DIQUELOU; P. LEES; P. L. TOUTAIN 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 258 KB